Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China

NCT05110261 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Lower Respiratory Tract Infection

Interventions

DRUG: Nirsevimab
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]